These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22498418)

  • 1. Alström syndrome: cardiac magnetic resonance findings.
    Corbetti F; Razzolini R; Bettini V; Marshall JD; Naggert J; Tona F; Milan G; Maffei P
    Int J Cardiol; 2013 Aug; 167(4):1257-63. PubMed ID: 22498418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study.
    Edwards NC; Moody WE; Yuan M; Warfield AT; Cramb R; Paisey RB; Geberhiwot T; Steeds RP
    Orphanet J Rare Dis; 2015 Jun; 10():83. PubMed ID: 26104972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alström syndrome is associated with short stature and reduced GH reserve.
    Romano S; Maffei P; Bettini V; Milan G; Favaretto F; Gardiman M; Marshall JD; Greggio NA; Pozzan GB; Collin GB; Naggert JK; Bronson R; Vettor R
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):529-36. PubMed ID: 23445176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation identification and prediction for severe cardiomyopathy in Alström syndrome, and review of the literature for cardiomyopathy.
    Dedeoglu S; Dede E; Oztunc F; Gedikbasi A; Yesil G; Dedeoglu R
    Orphanet J Rare Dis; 2022 Sep; 17(1):359. PubMed ID: 36109815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alström Syndrome: Mutation Spectrum of ALMS1.
    Marshall JD; Muller J; Collin GB; Milan G; Kingsmore SF; Dinwiddie D; Farrow EG; Miller NA; Favaretto F; Maffei P; Dollfus H; Vettor R; Naggert JK
    Hum Mutat; 2015 Jul; 36(7):660-8. PubMed ID: 25846608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis.
    Baig S; Dowd R; Edwards NC; Hodson J; Fabritz L; Vijapurapu R; Liu B; Geberhiwot T; Steeds RP
    Orphanet J Rare Dis; 2020 Jun; 15(1):139. PubMed ID: 32503575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of cardiomyopathy in Alström syndrome: Prospective single-center data on 38 patients.
    Brofferio A; Sachdev V; Hannoush H; Marshall JD; Naggert JK; Sidenko S; Noreuil A; Sirajuddin A; Bryant J; Han JC; Arai AE; Gahl WA; Gunay-Aygun M
    Mol Genet Metab; 2017 Aug; 121(4):336-343. PubMed ID: 28610912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey.
    Ozantürk A; Marshall JD; Collin GB; Düzenli S; Marshall RP; Candan Ş; Tos T; Esen İ; Taşkesen M; Çayır A; Öztürk Ş; Üstün İ; Ataman E; Karaca E; Özdemir TR; Erol İ; Eroğlu FK; Torun D; Parıltay E; Yılmaz-Güleç E; Karaca E; Atabek ME; Elçioğlu N; Satman İ; Möller C; Muller J; Naggert JK; Özgül RK
    J Hum Genet; 2015 Jan; 60(1):1-9. PubMed ID: 25296579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme clinical variability of dilated cardiomyopathy in two siblings with Alström syndrome.
    Mahamid J; Lorber A; Horovitz Y; Shalev SA; Collin GB; Naggert JK; Marshall JD; Spiegel R
    Pediatr Cardiol; 2013 Feb; 34(2):455-8. PubMed ID: 22447358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement.
    Nanjo S; Yoshikawa K; Harada M; Inoue Y; Namiki A; Nakano H; Yamazaki J
    Circ J; 2009 Oct; 73(10):1939-44. PubMed ID: 19729860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis.
    Zulato E; Favaretto F; Veronese C; Campanaro S; Marshall JD; Romano S; Cabrelle A; Collin GB; Zavan B; Belloni AS; Rampazzo E; Naggert JK; Abatangelo G; Sicolo N; Maffei P; Milan G; Vettor R
    PLoS One; 2011 Apr; 6(4):e19081. PubMed ID: 21541333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.